Alison Weissbrot
Jun 09, 2021

Bayer kicks off $800 million global media review

WPP’s Mediacom held a majority of the account, along with PHD in certain markets

Getty Images
Getty Images

Pharmaceutical giant Bayer has kicked off a global media review, Campaign US has learned. 

WPP’s MediaCom and Omnicom’s PHD are incumbents on the account, which is estimated to be worth $800 million globally, and are defending the business. A number of other holding companies are expected to participate in the pitch, including Dentsu and IPG.

MediaSense is advising on the review, but did not reply to requests for comment in time for publication.

In 2010, Bayer consolidated its $800 million media business outside of the U.S. with WPP, later handing its estimated $300 million U.S. remit to Mediacom in 2011. In 2014, PHD picked up Bayer’s global media account across five markets from incumbent Initiative, including the pharma giant’s home country, Germany.

In 2019, a Business Insider article wrongly reported that Bayer was putting its global media account into review. Bayer and WPP responded by publicly refuting the story and emphasizing that the pair were maintaining their relationship. 

Bayer has an in-housing component as part of its media buying operations in the U.S. In 2018 the company partnered with S4 Capital’s MightyHive to in-house its programmatic media buying, setting a goal to take most of its digital media buying in the region in-house by 2020. 

In the U.S. that effort was being led by Josh Palau, formerly head of media at Bayer North America. Palau, however, moved over to PHD as head of media activation, signaling a potential shift in strategy for the pharma giant. 

Pharmaceutical and healthcare brands have been a boon for agencies during the pandemic. The Bayer review is another example of a large, global business launching a global review to consolidate business with a single global partner. 

As one of the largest pharmaceutical companies in the world, Bayer operates a consumer health division that makes drugstore staples such as Alka-Seltzer, Claritin and Aleve, as well as a pharmaceutical and crop sciences division. 

PHD and MediaCom declined to comment. Bayer also declined to comment.

(This article first appeared on CampaignLive.com)

Source:
Campaign India

Related Articles

Just Published

6 hours ago

Campaign roundup: Week of 12 May

The latest ad films and campaigns from brands like Kingston Technology, Blum India, Hindustan Coca-Cola Beverages (HCCB), Hershey India, Lux Cozi, and more, in our weekly roundup.

12 hours ago

Brand campaigns celebrate values associated with ...

From menopause awareness to role reversals to mealtime shifts—brand campaigns highlight meaningful stories on Mother's Day 2025.

12 hours ago

Moves and wins roundup: Week of 12 May

Our weekly roundup of the latest appointments and account wins news from Madison Media Alpha, EndemolShine India, Mediascope, Primex Media Services, and many more.

14 hours ago

Striking a balance between design discipline and ...

In a world full of sameness, the most memorable brands are the ones that take creative risks while staying true to who they are, opines SummerOwl Studio's founder and creative director.